Therapeutic Resistance to Anti-hormonal Drugs in Breast Cancer New Molecular Aspects and their Potential as Targets /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Dordrecht :
Springer Netherlands : Imprint: Springer,
2009.
|
| Edición: | 1st ed. 2009. |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-1-4020-8526-0 |
Tabla de Contenidos:
- Experimental Endocrine Resistance: Concepts and Strategies
- Transcriptional Coactivators and Corepressors in Endocrine Response and Resistance in Breast Cancer
- The Re-Expression of Estrogen Receptor in Estrogen Receptor-Negative Breast Cancer and Restoration of Anti-Estrogen Responses
- The Dark Side of Antihormonal Action in Breast Cancer
- Influence of the Tumour Microenvironment
- Are Stem-Like Cells Responsible for Resistance to Therapy in Breast Cancer?
- HSP90 Inhibition as an Anticancer Strategy: Novel Approaches and Future Directions
- Adverse Features of Acquired Antihormone Resistance and Their Targeting
- Identifying Modifiers of Tamoxifen Sensitivity Using High-Throughput Genetic and Chemical Screens
- Endocrine Resistance in Breast Cancer- Where Are We NowWith Intelligent Combination Therapies?.